London, 6 May 2021, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce the appointment of Matthew Cole as Partner.
Matthew is a senior communications advisor with more than 15 years’ experience in both in-house and advisory roles within healthcare. He has specialist expertise in financial and corporate communications and investor relations and has been a trusted adviser to Boards and senior management at some of the world’s largest healthcare companies including Smith & Nephew, Hikma, Shire, Novartis, Bupa and UCB.
Most recently, Matthew was Communications Director for Arix Bioscience plc, a London-listed biotech venture capital company. Prior to that, he spent more than a decade at FTI Consulting in London working in a succession of roles within its healthcare & life sciences and investor relations teams.
“I am very pleased to welcome Matthew as a Partner in our firm. He brings a wealth of experience to our team, and further expands our strength and capabilities at a senior level. His appointment reflects Consilium’s continued growth and commitment to delivering the highest quality advice and service for our clients.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
“I am delighted to join Consilium, a clear leader in strategic healthcare communications and investor relations. I look forward to our continued growth as trusted advisors helping established and developing companies achieve their goals to deliver valuable innovation for patients and healthcare providers.”
Matthew Cole
Newly appointed Partner of Consilium Strategic Communications
